In May 2011, the U.S. Food and Drug Administration (FDA) ordered manufacturers of metal-on-metal hip replacements to conduct post market surveillance studies of their devices after receiving complaints about metal poisoning and early failure rates involving multiple devices from different manufacturers.
The FDA’s order came on the heels of Johnson and Johnson’s (J&J) DePuy ASR hip replacement recall in 2010.
After the ASR recall, patients experienced problems with another DePuy device—the metal-on-metal Pinnacle hip device. Rather than issuing another DePuy recall of the Pinnacle, J&J discontinued sale of the Pinnacle in August 2013.
More than 8,000 recipients of the DePuy ASR who filed hip replacement lawsuits are expected to receive compensation under the DePuy hip settlement. Pinnacle patients are still seeking compensation, and a number of Pinnacle lawsuits are awaiting trial.
Pennsylvania personal injury attorney Thomas Anapol, who was instrumental in negotiating the Biomet and Stryker metal-on-metal hip implant lawsuit settlements, is currently filing DePuy Pinnacle lawsuits on behalf of injured patients. Anyone who suspects their Pinnacle hip is failing is urged to contact Tom to discuss filing a hip replacement lawsuit.
The Legal Examiner and our Affiliate Network strive to be the place you look to for news, context, and more, wherever your life intersects with the law.
Comments for this article are closed.